ADC Therapeutics's market cap is currently $162.44M. The company's EPS TTM is $-2.399; its P/E ratio is ―; ADC Therapeutics is scheduled to report earnings on March 13, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 69.56M	$ 209.91M	$ 33.92M	$ 0.00	$ 2.34M
Gross Profit	$ 67.03M	$ 205.33M	$ 32.52M	$ -1.97M	$ -105.20M
Operating Income	$ -165.99M	$ -123.63M	$ -261.72M	$ -219.26M	$ -119.40M
EBITDA	$ -146.76M	$ -108.06M	$ -223.72M	$ -219.26M	$ -114.10M
Net Income	$ -240.05M	$ -155.80M	$ -230.03M	$ -246.29M	$ -116.48M
Balance Sheet
Cash & Short-Term Investments	$ 278.60M	$ 326.44M	$ 466.54M	$ 439.19M	$ 115.55M
Total Assets	$ 354.78M	$ 529.17M	$ 617.97M	$ 513.69M	$ 137.68M
Total Debt	$ 124.38M	$ 117.38M	$ 101.75M	$ 41.87M	$ 5.03M
Net Debt	$ -154.22M	$ -209.07M	$ -364.79M	$ -397.32M	$ -110.52M
Total Liabilities	$ 503.03M	$ 440.44M	$ 451.88M	$ 178.19M	$ 26.53M
Stockholders' Equity	$ -148.25M	$ 88.73M	$ 166.09M	$ 335.50M	$ 111.16M
Cash Flow
Free Cash Flow	$ -121.90M	$ -139.09M	$ -239.75M	$ -171.54M	$ -123.73M
Operating Cash Flow	$ -118.69M	$ -136.79M	$ -233.38M	$ -168.73M	$ -121.58M
Investing Cash Flow	$ -3.22M	$ -2.51M	$ -6.67M	$ -2.83M	$ -2.25M
Financing Cash Flow	$ 73.88M	$ -593.00K	$ 267.39M	$ 494.97M	$ 100.51M

Currency in USD

ADC Therapeutics Earnings and Revenue History

Income Statement >

ADC Therapeutics Debt to Assets

Balance Sheet >

ADC Therapeutics Cash Flow

Cash Flow >

ADC Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing